bone marrow transplant
Showing 51 - 75 of >10,000
Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloma Trial in Bergamo (Patient registry)
Recruiting
- Hodgkin Lymphoma
- +2 more
- Patient registry
-
Bergamo, ItalyHematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa G
Dec 22, 2021
Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)
Not yet recruiting
- Stem Cell Transplant Complications
- Eltrombopag 25 MG Oral Tablet
- Thrombopoietin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 17, 2022
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)
Recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Personalized rATG (P-rATG)
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 31, 2022
SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy
Recruiting
- Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
- COVID-19 serology IgG
-
Detroit, MichiganHenry Ford Health System
Jul 19, 2022
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bone Marrow Hematopoeitic Cell Transplant (HCT)
- +9 more
- (no location specified)
Sep 27, 2021
Sensorineural Hearing Loss Trial in Orlando (Autologous Bone Marrow Infusion)
Suspended
- Sensorineural Hearing Loss
- Autologous Bone Marrow Infusion
-
Orlando, FloridaFlorida Hospital for Children
Mar 16, 2022
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,
Recruiting
- DOCK8 Deficiency
- Reduced-intensity hematopoietic stem cell
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)
Completed
- Multiple Myeloma
- Amyloidosis
- Tacrolimus
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Aug 24, 2021
Bone Marrow Transplant, Information Disclosure, Hematopoietic Stem Cell Transplantation Trial in Phoenix (Baseline Surveys,
Completed
- Bone Marrow Transplant
- +7 more
- Baseline Surveys
- +2 more
-
Phoenix, ArizonaMayo Clinic
May 20, 2022
Strongyloides Stercoralis in Bone Marrow Transplant Recipients
Not yet recruiting
- Strongyloidiasis
- Bone Marrow Transplant Infection
- None - standard of care
- (no location specified)
Jan 13, 2021
HIV Trial run by the NIAID (CD4-IgG, Zidovudine, Interferon alfa-n1)
Completed
- HIV Infections
- CD4-IgG
- +4 more
-
Bethesda, MarylandNatl Inst of Allergy & Infect Dis / Cln Ctr
Oct 26, 2021
Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)
Withdrawn
- Hematologic Diseases
- +5 more
- CliniMACS
- +7 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022
Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in
Active, not recruiting
- Bone Marrow Transplantation Recipient
- +2 more
- Eltrombopag Olamine
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)
Not yet recruiting
- Recurrent Severe Aplastic Anemia
- Refractory Severe Aplastic Anemia
- Anti-Thymocyte Globulin
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 23, 2023
Renal Failure Trial in Boston (Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab, Combined bone marrow
Recruiting
- Renal Failure
- Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
- Combined bone marrow and kidney transplant
-
Boston, MassachusettsMassachusetts General Hospital
Jan 19, 2023
Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,
Recruiting
- Severe Sickle Cell Disease
- +5 more
- RIC regimen
- GVHD prophylaxis regimen
-
New Haven, Connecticut
- +1 more
Feb 4, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
Bone Marrow Transplantation Trial in Lexington (BMT Physical Activity app, Watch Only)
Recruiting
- Bone Marrow Transplantation
- BMT Physical Activity app
- Watch Only
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Apr 26, 2021
B-cell Adult Acute Lymphoblastic Leukemia, Stem Cell Leukemia, Minimal Residual Disease Trial in Vancouver, Halifax
Terminated
- B-cell Adult Acute Lymphoblastic Leukemia
- +2 more
- blinatumomab
-
Vancouver, British Columbia, Canada
- +2 more
Feb 3, 2022
Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid
Active, not recruiting
- Mycoses
- +5 more
- anti-thymocyte globulin
- +2 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 16, 2022